Owen Mumford Unistik 3 Pre-Set Single Use Safety Lancets - Extra 21G
Brand: Owen Mumford
USD 24.53 — In stock
How to order
In stock — USD 24.53.
Prefer to order with a person? +1 855 932 4721 · info@priconmed.com · Contact us.
Variants
- Lancet, Extra, 21G, 2.0mm Penetration Depth, Orange, 100/bx — USD 24.53 — In stock — SKU AT1012
- Lancet, Extra, 21G, 2.0mm Penetration Depth, Orange, 200/bx — USD 39.98 — In stock — SKU AT1014
- Lancet, Extra, 21G, 2.0mm Penetration Depth, Orange, 1000/cs — USD 206.39 — In stock — SKU AT1013
Product intelligence — AI-assisted — defer to the manufacturer's IFU
01 — At a glance
Product overview
The Owen Mumford Unistik 3 Extra is a single-use safety lancet designed for clinical blood sampling. This 21G device features Comfort Zone Technology, utilizing eight pressure points to reduce pain signals during the fingerstick process.
- Brand
- Owen Mumford
- Needle Gauge
- 21G
- Penetration Depth
- 2.0mm
- Color Code
- Orange
- Packaging Options
- 100/bx, 200/bx, 1000/cs
- Technology
- Comfort Zone Technology
How to think about this product
When selecting between Unistik 3 models, the Extra (21G, 2.0mm) is positioned for standard blood flow requirements. Buyers should prioritize this model when patient comfort is a concern, as the integrated pressure-point technology differentiates it from standard safety lancets. The color-coded orange housing helps staff quickly identify the 21G/2.0mm specification in busy clinical environments.
02 — Clinical applications
Where this product is used
Owen Mumford Unistik 3 Pre-Set Single Use Safety Lancets - Extra 21G is commonly used in:
- Capillary blood sampling for medical testing
- Point-of-care diagnostic testing in clinics
- Routine fingersticks in ambulatory surgery centers
- Blood glucose monitoring in urgent care
03 — People also ask
Frequently asked questions
Q01 Who manufactures Owen Mumford Unistik 3 Pre-Set Single Use Safety Lancets - Extra 21G?
Owen Mumford Unistik 3 Pre-Set Single Use Safety Lancets - Extra 21G is manufactured by Owen Mumford. PriconMed sources this item through authorized supply channels so the lot, packaging, and expiration date match what Owen Mumford ships from the factory.
Q02 What type options are available?
This product is offered in 3 variants based on type. Use the selector on this page (or the variant table) to see SKUs, current stock, and per-unit pricing for each option.
Q03 Is bulk or contract pricing available?
Yes. Verified facilities ordering full cases of Owen Mumford Unistik 3 Pre-Set Single Use Safety Lancets - Extra 21G — or building a standing order — can request a custom quote from our wholesale team and qualify for tiered pricing and net-30 terms.
Q04 How quickly does this ship?
In-stock orders for Owen Mumford Unistik 3 Pre-Set Single Use Safety Lancets - Extra 21G are handled at our St. Louis Park, Minnesota warehouse in 0–5 business days (3 PM CST cutoff) and arrive in 3–11 business days total, including 3–6 business days in transit. Ground shipping is a flat $9.99 and free on orders of $250 or more. You'll see the live in-stock count on this page; if the item is low, contact us for an ETA before placing a large order.
Q05 Can I return this product if it doesn't work for my facility?
Unopened, in-date medical supplies in original packaging can be returned within 60 days — return by mail with a free downloadable label, restocking fee $0 (none), and refunds are processed within 5 days of receipt. Sterile or opened items cannot be returned for infection-control reasons. See our Returns policy for the full process.
Q06 Is this HSA/FSA eligible?
Most medical supplies sold by PriconMed — including Lancets/Blades/platforms/devices — are eligible for purchase with HSA and FSA funds when used for a qualifying medical condition. Save your PriconMed invoice for reimbursement.
04 — Wholesale · For verified medical professionals
Need a bulk quote?
Ordering 5+ cases or stocking a facility? Our wholesale team can offer custom pricing, standing orders, and net-30 terms.
- Net-30 terms
- Custom pricing
- 1 business day response